Related Experiment Videos
Extracranial atherosclerosis and cerebrovascular disease. Minimizing the risk of stroke
1Lahey Clinic Medical Center, Burlington, Massachusetts.
Insights
Extracranial atherosclerotic cerebrovascular disease increases risk for heart attack and stroke. Managing risk factors like hypertension and diabetes, alongside therapies such as antiplatelet agents, can improve outcomes for affected patients.
Area of Science:
- Neurology
- Cardiology
- Vascular Medicine
Background:
- Extracranial atherosclerotic cerebrovascular disease is a significant risk factor for major cardiovascular events, including myocardial infarction and stroke.
- Identifying and managing this condition is crucial for patient outcomes.
Purpose of the Study:
- To outline the management strategies for patients with extracranial atherosclerotic cerebrovascular disease.
- To differentiate treatment approaches for asymptomatic versus symptomatic patients.
Main Methods:
- Review of existing literature and clinical guidelines on extracranial atherosclerotic cerebrovascular disease management.
- Analysis of risk factors and therapeutic interventions.
Main Results:
- Asymptomatic patients benefit from aggressive modification of stroke risk factors: hypertension, hyperlipidemia, diabetes mellitus, and smoking cessation.
- Symptomatic patients with focal brain ischemia may require antiplatelet therapy, anticoagulation, and surgical intervention in addition to risk factor modification.
Conclusions:
- Comprehensive management, including risk factor control and targeted therapies, is essential for patients with extracranial atherosclerotic cerebrovascular disease.
- Treatment should be individualized based on patient symptoms and disease severity.
Abstract:
Extracranial atherosclerotic cerebrovascular disease is a risk factor for myocardial infarction and stroke. Asymptomatic patients with evidence of disease may benefit from modification of risk factors for stroke (ie, hypertension, hyperlipidemia, diabetes mellitus, and cigarette smoking). Symptomatic patients with focal brain ischemia may benefit from antiplatelet therapy, anticoagulation, and surgery in addition to modification of risk factors.